US Federal Workers File Class Action Against Trump Policy Curtailing Gender-Affirming Care

Spread the Message

Read Time:8 Minute, 9 Second

Federal Employees Move to Block New Coverage Ban

A group of U.S. federal government employees has filed a class action complaint challenging President Donald Trump’s new policy that will eliminate insurance coverage for gender-affirming medical care under federal employee health plans starting in 2026. The complaint, filed on January 1, 2026, targets changes to the Federal Employees Health Benefits (FEHB) and Postal Service Health Benefits (PSHB) programs overseen by the Office of Personnel Management (OPM), arguing that the policy unlawfully discriminates against transgender workers and their families on the basis of sex.

What the New Policy Does

The contested policy stems from an August 2025 OPM letter instructing health carriers that “chemical and surgical modification of an individual’s sex traits through medical interventions,” including gender transition services, will no longer be covered under FEHB plans beginning with the 2026 plan year. The change affects more than 8 million people who rely on FEHB and related programs, including federal employees, retirees, postal workers, and their dependents.

Under the guidance:

Gender-affirming hormone therapy and surgeries for transgender people will be excluded from coverage for all ages, not just minors.
A narrow set of exceptions remains, including case‑by‑case continuation of coverage for some individuals already in treatment and hormone therapy for non–gender-related conditions such as cancer.
Counseling and other mental health services for people with possible or diagnosed gender dysphoria must still be covered if provided by licensed professionals or approved faith-based counselors.

This insurance shift builds on earlier Trump executive orders issued in 2025 that directed federal agencies to interpret sex in law and policy strictly as biological sex and framed certain forms of gender-affirming care, especially for minors, as harmful.

Legal Claims and Civil Rights Arguments

The federal workers’ complaint contends that eliminating coverage for gender-affirming care constitutes unlawful sex discrimination under both the U.S. Constitution and federal civil rights statutes. Advocates argue that treating gender-affirming care differently from other medically necessary treatments for comparable conditions violates equal protection and Title VII of the Civil Rights Act, which prohibits discrimination in employment benefits, as recognized by the Supreme Court’s 2020 decision in Bostock v. Clayton County.

LGBTQ+ legal organization Lambda Legal has condemned the OPM policy as “cruel” and “illegal,” asserting that the federal government “cannot simply strip away essential healthcare coverage from transgender employees while providing comprehensive medical care to all other federal workers.” The Human Rights Campaign Foundation, which is supporting the complainants, has indicated that if OPM does not rescind the policy, it will escalate the matter to the Equal Employment Opportunity Commission (EEOC) and could pursue a broader class action in federal court.

What Gender-Affirming Care Includes

Gender-affirming care is an umbrella term for medical and psychosocial interventions that support a person whose gender identity differs from their sex assigned at birth. For adolescents and adults, clinical guidelines from major professional bodies, such as the World Professional Association for Transgender Health (WPATH) and the Endocrine Society, typically include:

Mental health support: Assessment and ongoing counseling for gender dysphoria and related concerns.
Hormone therapy: Use of estrogen or testosterone to induce physical changes aligned with a person’s gender identity, with monitoring of risks like blood clots, cardiovascular disease, bone health, and fertility.
Surgical interventions: Procedures such as chest reconstruction, genital surgery, or facial surgery in appropriately evaluated adults.

Research suggests that access to gender-affirming care is associated with improved mental health outcomes, including lower rates of depression, anxiety, and suicidal ideation among transgender people. A Human Rights Watch report in 2025, for example, documented worsening mental health and abrupt treatment interruptions in transgender youth when access to gender-affirming care was restricted.

Expert Perspectives on Medical and Ethical Implications

Many clinical and human rights organizations describe gender-affirming care, when delivered in line with established guidelines, as medically necessary for people with persistent gender dysphoria. In a statement responding to the FEHB changes, Dr. Jamila Perritt, an obstetrician-gynecologist and president of Physicians for Reproductive Health, called the policy “a discriminatory action” that places transgender federal workers and their families “in medically dangerous situations by denying them the lifesaving care they need.”

Legal and bioethics experts also highlight the precedent such a policy might set. Health law scholars note that tying access to medically recognized treatments to a person’s gender identity, rather than to clinical need and professional standards, risks undermining core principles of nondiscrimination in healthcare. At the same time, supporters of the Trump administration’s approach have invoked religious liberty and parental rights, arguing that providers or institutions should not be compelled to offer services that conflict with their beliefs and that more caution is warranted about long-term effects of gender-affirming treatments, particularly in minors.

Broader Policy Context and Ongoing Federal Actions

The FEHB coverage ban is part of a wider suite of Trump administration actions aimed at restricting gender-affirming care across federal programs. Recent initiatives include:

A proposed rule that would bar hospitals providing gender-affirming care to minors from receiving Medicare and Medicaid funding and would prevent the Children’s Health Insurance Program (CHIP) from covering specified gender-affirming services.
Federal investigations into health systems over religious exemption claims related to gender-affirming care, invoking longstanding “conscience” laws originally written around abortion and sterilization.
An executive order and subsequent guidance that limited coverage of gender-affirming care for minors in FEHB before the broader ban for adults was announced.

These moves have prompted pushback not only from civil rights groups but also from a coalition of Democratic state attorneys general, who recently sued to block proposed federal rules that would further restrict children’s access to gender-affirming care.

Impact on Transgender Federal Employees and Families

For transgender federal workers and their dependents, the policy could mean a sudden loss of coverage for care they have relied on for years. Individuals currently receiving hormone therapy or surgical care may qualify for limited “continuity of care” exceptions, but advocates caution that these are discretionary and could lead to uneven access across different plans and carriers.

If coverage ends, affected individuals may face:

Significant out-of-pocket expenses for ongoing hormone therapy, routine lab monitoring, and follow-up visits. Depending on regimen and location, annual costs can reach several thousand dollars.
Delayed or canceled surgeries due to prohibitive costs, which may worsen gender dysphoria and associated mental health challenges.
Increased vulnerability to discrimination if providers who remain willing to offer care are concentrated in certain regions or are out-of-network.

Advocates stress that continuity of care is especially important in hormone-based treatments, where abrupt discontinuation can cause both physical and psychological distress, such as mood destabilization, sleep changes, and return of unwanted secondary sex characteristics.

What This Means for Patients and Clinicians

For readers—whether federal workers, family members, or clinicians—the policy underscores the importance of anticipating potential changes in coverage and planning for continuity of medically necessary care. While legal challenges may alter the policy’s future, affected individuals can consider several practical steps in consultation with their healthcare teams:

Review current plan documents and upcoming open-enrollment materials to understand how gender-affirming services are categorized and whether any transition provisions apply.
Discuss with clinicians whether any time-sensitive components of care, such as surgical steps or medication adjustments, can be scheduled or documented well in advance, ensuring clear medical records that could support exception requests.
Explore state-level protections and private insurance options where available, as some states have nondiscrimination laws or insurance regulations that explicitly protect coverage for gender-affirming care.

Healthcare professionals who treat transgender patients may also need to:

Clarify insurance restrictions and appeal pathways with patients, including prior authorization processes and documentation requirements for gender dysphoria diagnoses.
Coordinate with mental health providers to support patients experiencing increased stress, uncertainty, or stigma related to policy changes.
Stay updated on evolving federal and state regulations, as legal outcomes in these cases may shift coverage rules, provider obligations, and patient rights over the next several years.

Limitations, Uncertainties, and Ongoing Debate

Evidence around gender-affirming care continues to grow, but there are ongoing debates about optimal age thresholds, specific interventions for adolescents, and long-term outcomes across different populations. Some systematic reviews have noted moderate-quality evidence for improvements in mental health and quality of life with gender-affirming interventions, while also emphasizing the need for more long-term, controlled studies.

Policy discussions are further complicated by differing interpretations of the same data and by the blending of scientific, ethical, and political arguments. Critics of broad restrictions argue that decisions about gender-affirming care should be guided primarily by individualized clinical assessment and shared decision-making between patients, families, and multidisciplinary care teams. Supporters of the Trump administration’s restrictions contend that the state has a role in limiting or scrutinizing interventions they perceive as high risk or insufficiently studied, especially for minors, and in protecting religious objectors in healthcare settings.

As the legal challenge from federal workers and parallel lawsuits from state officials proceed, courts will likely be asked to weigh not only the scope of federal civil rights protections for transgender people, but also how far federal agencies can go in reshaping access to gender-affirming care through insurance and funding rules.

Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.